Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
Working Capital/Sales

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 1.421.241.251.151.25

What is the latest Working Capital/Sales ratio of NATCO PHARMA ?

The latest Working Capital/Sales ratio of NATCO PHARMA is 1.42 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20241.42
Mar20231.24
Mar20221.25
Mar20211.15
Mar20201.25

How is Working Capital/Sales of NATCO PHARMA Trending?

Years Working Capital/Sales % Change
Mar2024 1.42
14.52
Mar2023 1.24
-0.80
Mar2022 1.25
8.70
Mar2021 1.15
-8.00
Mar2020 1.25 -

Other Financial Ratios of NATCO PHARMA


Compare Working Capital/Sales ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,070.4 Cr -5.4% 2.3% -17.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹438,778.0 Cr 2.3% 5.6% 21.7% Stock Analytics
DIVIS LABORATORIES ₹161,949.0 Cr 1.5% 4.2% 51.2% Stock Analytics
CIPLA ₹123,222.0 Cr 0% 2.9% 10% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,205.0 Cr 0.6% 0.9% 23.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,707.7 Cr 0.8% 1.8% -5.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-5.4%

2.3%

-17.5%

SENSEX

0.9%

4.2%

8.3%


You may also like the below Video Courses